I Ethics, Law, and Policy Biosketch

Mark Chee, Ph.D.

Dr. Chee is an internationally recognized expert in nucleic acid analysis and oligonucleotide array technology. He presently serves as Chief Executive Officer and Chief Scientific Officer of Prognosys Biosciences, Inc. Previously he was a cofounder of Illumina, Inc., and Senior Scientist at Affymetrix, Inc. Dr. Chee is currently active in the development of microbead, biochip, and microarray techniques for studying the genome. He has numerous publications and patents and serves on the editorial board of Genome Research. His articles have appeared in more than 30 peer-reviewed journals and he has ownership of more than 40 issued patents.